Bridge Genomics
Toronto
About Bridge Genomics
Bridge Genomics brings together world leaders in genome and computational biology. They have pioneered new technologies to map and analyze large-scale genetic networks and are inventing new technologies to discover how combinations of different mutations encoded in their genomes impact susceptibility to disease and other inherited traits. Their mission is to improve diagnostics and therapeutics for disease through combinatorial analysis of human genetic data.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Last round: Non-Equity Assistance (Oct 2016)
- Website: bridgegenomics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science
Canonical: https://fsome.com/organization/bridge-genomics-3772576 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.